← Leaderboards
Sabra Inslicht
Veterans Affairs Med Ctr San Francisco
$0
Attributed
$0
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2014–25$1$1$1$0$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 3
By mechanism
I01$0 · 3
Top collaborators
No co-investigators on record.
Most similar at Veterans Affairs Med Ctr San Francisco
Same institution · by research overlap
- Anne Richards$0
- Lizabeth Goldstein$635,254
- Adam R Ferguson$9,293,745
- Shira Maguen$0
Research focus
Post-Traumatic Stress DisordersFrightSymptomsVeteransLearningLearning ExtinctionReportingSafetyStressSeveritiesAccountingTraumaReceptorStartle ReactionPlacebosDistressNeuropeptidesCombatPharmaceutical PreparationsPre-ClinicalClinical TrialsArousalAutonomic Nervous SystemImpairment
Grant awards (15)
The Effects of Orexin Antagonism on Fear Extinction in PTSD$0
I01 · FY2025 · VA · contact PI
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress$0
I01 · FY2025 · VA · contact PI
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress$0
I01 · FY2024 · VA · contact PI
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress$0
I01 · FY2023 · VA · contact PI
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress$0
I01 · FY2022 · VA · contact PI
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD$0
I01 · FY2021 · VA · contact PI
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress$0
I01 · FY2021 · VA · contact PI
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD$0
I01 · FY2020 · VA · contact PI
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress$0
I01 · FY2020 · VA · contact PI
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD$0
I01 · FY2019 · VA · contact PI
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress$0
I01 · FY2019 · VA · contact PI
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD$0
I01 · FY2017 · VA · contact PI
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD$0
I01 · FY2016 · VA · contact PI
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD$0
I01 · FY2015 · VA · contact PI
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD$0
I01 · FY2014 · VA · contact PI